Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Sep;94(3):498-505.
doi: 10.1016/j.gie.2021.03.937. Epub 2021 Apr 20.

Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study

Prasad G Iyer  1 , William R Taylor  1 , Seth W Slettedahl  2 , Ramona L Lansing  1 , Lois L Hemminger  3 , Frances K Cayer  3 , Douglas W Mahoney  2 , Maria Giakoumopoulos  4 , Hatim T Allawi  4 , Tsung-Teh Wu  5 , Kenneth K Wang  1 , Herbert C Wolfsen  3 , Eduardo Antpack  6 , John B Kisiel  1
Affiliations
Multicenter Study

Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study

Prasad G Iyer et al. Gastrointest Endosc. 2021 Sep.

Abstract

Background and aims: We previously identified a 5 methylated DNA marker (MDM) panel for the detection of nonendoscopic Barrett's esophagus (BE). In this study, we aimed to recalibrate the performance of the 5 MDM panel using a simplified assay in a training cohort, validate the panel in an independent test cohort, and explore the accuracy of an MDM panel with only 3 markers.

Methods: Participants were recruited from 3 medical centers. The sponge on a string device (EsophaCap; CapNostics, Concord, NC, USA) was swallowed and withdrawn, followed by endoscopy, in BE cases and control subjects. A 5 MDM panel was blindly assayed using a simplified assay. Random forest modeling analysis was performed, in silico cross-validated in the training set, and then locked down, before test set analysis.

Results: The training set had 199 patients: 110 BE cases and 89 control subjects, and the test set had 89 patients: 60 BE cases and 29 control subjects. Sensitivity of the 5 MDM panel for BE diagnosis was 93% at 90% specificity in the training set and 93% at 93% specificity in the test set. Areas under the receiver operating characteristic curves were .96 and .97 in the training and test sets, respectively. Model accuracy was not influenced by age, sex, or smoking history. Multiple 3 MDM panels achieved similar accuracy.

Conclusions: A 5 MDM panel for BE is highly accurate in training and test sets in a blinded multisite case-control analysis using a simplified assay. This panel may be reduced to only 3 MDMs in the future. (Clinical trial registration number: NCT02560623.).

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
EsophaCap capsule sponge device. A, Intact. B, Expanded.
Figure 1:
Figure 1:
EsophaCap capsule sponge device. A, Intact. B, Expanded.
Figure 2:
Figure 2:
Areas under the receiver operating characteristic curves (AUCs) in the training and test sets for Barrett’s esophagus detection using a 5 methylated DNA marker panel.
See this image and copyright information in PMC

Comment in

References

    1. Shaheen NJ, Falk GW, Iyer PG, et al.ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol 2016;111:30–50; quiz 51. - PMC - PubMed
    1. Vaughan TL, Fitzgerald RC. Precision prevention of oesophageal adenocarcinoma. Nat Rev Gastroenterol Hepatol 2015;12:243–8. - PMC - PubMed
    1. Jung KW, Talley NJ, Romero Y, et al.Epidemiology and Natural History of Intestinal Metaplasia of the Gastroesophageal Junction and Barrett’s Esophagus: A Population-Based Study. Am J Gastroenterol 2011;106:1447–55. - PMC - PubMed
    1. Cooper GS, Kou TD, Chak A. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol 2009;104:1356–62. - PubMed
    1. Moinova HR, LaFramboise T, Lutterbaugh JD, et al.Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett’s esophagus. Sci Transl Med 2018;10. - PMC - PubMed

Publication types

Substances

Associated data